USPTO serial 79223494
CELLSPRESSO
Reviewed by CopyMark Law Group
Reg. 5634962Status 709
- Filing date
- Status date
- Registration date
- Dec 25, 2018
- Examiner
- BERLIN, JUSTIN E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CELLSPRESSO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Melanie Howard
Melanie Howard Loeb & Loeb LLP10100 Santa Monica Blvd., Suite 2200Los Angeles, CA 90067UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts in the nature of treatment for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; veterinary pharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts in the nature of treatment for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; pharmaceutical preparations and substances for the treatment of damaged skin and tissue, namely, tissue regenerative pharmaceutical preparations; cellular medicines, namely, stem cells for medical or veterinary use; reagents for medical or veterinary use; clinical medical and veterinary reagents; medical and veterinary diagnostic reagents; reagents for medical and veterinary diagnosis and medical and veterinary diagnostic research; chemical reagents for testing aqueous solutions for medical and veterinary purposes; reagents for use in biological processing for medical and veterinary purposes; media for biological and bacteriological cultures for medical and veterinary use; non-aqueous solvents for use in tests for medical and veterinary purposes; aqueous solutions for use in tests for medical and veterinary purposes; non-aqueous culture media for medical and veterinary use; chemicals preparations, namely, buffer solutions for use in tests for medical and veterinary purposes; chemicals, namely, surfactants for use in tests for medical and veterinary purposes | SECTION 71 - CANCELLED | — |
| 010 | Medical and veterinary devices, namely, instruments for the preparation of regenerative cells for implantation into humans and animals for the treatment of damaged and diseased skin, tissue, organs and body parts; disposable cartridges for medical and veterinary devices, namely, instruments for the preparation of regenerative cells for implantation into humans and animals for the treatment of damaged and diseased skin, tissue, organs and body parts; portable medical and veterinary apparatus, namely, instruments for the preparation of regenerative cells for implantation into humans and animals for the treatment of damaged and diseased skin, tissue, organs and body parts; surgical, medical, and veterinary apparatus, devices, and instruments for use in implanting regenerative cells into humans and animals to treat damaged and diseased skin, tissue, organs and body parts; surgical, medical, and veterinary apparatus, devices, and instruments for use in cell therapy and regenerative medicine; medical and veterinary devices, namely, applicators to implant regenerative cells into humans and animals for the treatment of damaged and diseased skin, tissue, organs and body parts; sample preparation devices for medical diagnostic use; apparatus for the regeneration of stem cells for medical purposes; component parts and fittings for all of the aforesaid | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cell Therapy Limited
- Other trademarks owned by Cell Therapy Limited
- Other trademarks owned by Cell Therapy Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named CELLSPRESSO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 11, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 11, 2025 | C71T | CANCELLED SECTION 71 | — |
| Dec 25, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 4, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 25, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 26, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 5, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 5, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 25, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 25, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 9, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 9, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 6, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 19, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 19, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 19, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 28, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 3, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 3, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 3, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 3, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 19, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 18, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 18, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 16, 2018 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jan 26, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 26, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 19, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 18, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 30, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 26, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 26, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 21, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |